Market by Procedure, Type of Infection, Industry Vertical, Product, and Region | Forecast 2021-2028
The detailed analysis of the global surgical site infection control (SSI) market shows that, in terms of revenue, the industry is estimated to grow at a CAGR of 5.95% during the forecasting years 2021-2028. The market accounted for $4389.4 million in 2020, and is expected to amount to $6969.5 million by 2028. Surgical site infection is an infection that arises post-surgery in that body part where the surgery was directed. Surgical site infections can be deep incisional, superficial, and organ-related.
The key factors
propelling the market for surgical site infection control are the rise in
hospital-acquired infections, regulatory guidelines for hospital infection
prevention & control, a rapidly growing geriatric population, and an increasing
number of surgeries. For instance, according to data from World Population
Prospects: the 2019 Revision, by 2050, one in six people in the world will be
over age 65 (16%), up from one in eleven in 2019 (9%).
The study aims to get
an overview of the surgical site infection control market in terms of various
factors. Within this report, the key insights and the market definition regarding
the surgical site infection control industry have been discussed. Also, industry
components like Porter’s five forces model, Impact of COVID-19 on the surgical
site infection control market, market attractiveness index, and vendor
scorecard have been studied in detail.
Drivers like an enactment
of the best infection prevention & control practices and the growing aging
population are driving the surgical site infection control market growth.
However, the industry is facing restraints like a lack of infection control
programs, surging use of outpatient procedures, and increased usages of medical
disposable items, which are obstructing its growth.
Key opportunities like the rising incidence of surgical procedures and the significant rise in the occurrence of complications from healthcare-associated infections can be leveraged by the industry to reach the projected growth.
Geographies
covered in the surgical site infection control market by region are:
• North America: Canada and United
States
• Europe: United Kingdom, Germany,
Russia, Spain, Italy, France, and Rest of Europe
• Asia-Pacific: Japan, South Korea,
India, ASEAN countries, China, Australia & New Zealand, and Rest of
Asia-Pacific
• Latin America: Mexico, Brazil, and
Rest of Latin America
• Middle East and Africa: Israel, Turkey,
United Arab Emirates, South Africa, Saudi Arabia, and Rest of Middle East &
Africa
The
surgical site infection control market has been segmented as follows:
• By Procedure
O Laparoscopy
O Orthopedic Surgery
O Cardiovascular
O Obstetrics and Gynecology
O Wound Closure
O Plastic & Reconstructive Surgery
O Thoracic Surgery
O Microvascular
O Urology
O Neurosurgery
O Other Procedures
• By Type of infection
O Superficial Incisional SSI
O Deep Incisional SSI
O Organ or Space SSI
• By Industry Vertical
O Hospitals
O Ambulatory Surgical Centers
• By Product
O Disinfectants
• Skin Disinfectants
• Hand Disinfectants
O Manual Reprocessors Solution
O Surgical Drapes
O Surgical Gloves
O Skin Preparation Solution
O Surgical Irrigation
O Surgical Scrubs
O Hair Clippers
O Medical Nonwovens
O Other Products
The key players engaged
in the surgical site infection control market are Belimed AG, 3M Company,
Stryker Corporation, Lac-Mac, American Polyfilm, Pacon Manufacturing
Corporation, Ansell Ltd, Sotera Health LLC, Gama Healthcare, Johnson &
Johnson, Becton Dickinson and Company (BD), Steris Corporation, Kimberly-Clark,
Biomerieux SA, and Getinge AB.
The strategic analysis
for each of these companies has been covered in detail. The surgical site
infection control market by company profile helps to dive into the data about
the key market players in this industry.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. GLOBAL
SURGICAL SITE INFECTION CONTROL MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. MARKET
DEFINITION
2.2. PORTER’S
FIVE FORCES MODEL
2.2.1. THREAT
OF NEW ENTRANTS
2.2.2. THREAT
OF SUBSTITUTE PRODUCTS
2.2.3. BARGAINING
POWER OF BUYERS
2.2.4. BARGAINING
POWER OF SUPPLIERS
2.2.5. COMPETITIVE
RIVALRY
2.3. IMPACT
OF COVID-19 ON SURGICAL SITE INFECTION CONTROL MARKET
2.4. MARKET
ATTRACTIVENESS INDEX
2.5. VENDOR
SCORECARD
2.6. KEY
INSIGHTS
2.7. MARKET
DRIVERS
2.7.1. ENACTMENT
OF THE BEST INFECTION PREVENTION AND CONTROL PRACTICES
2.7.2. GROWING
AGING POPULATION
2.8. MARKET
RESTRAINTS
2.8.1. LACK
OF INFECTION CONTROL PROGRAMS
2.8.2. SURGING
USE OF OUTPATIENT PROCEDURES
2.8.3. INCREASED
USAGES OF MEDICAL DISPOSABLE ITEMS
2.9. MARKET
OPPORTUNITIES
2.9.1. RISING
INCIDENCE OF SURGICAL PROCEDURES
2.9.2. SIGNIFICANT
RISE IN THE OCCURRENCE OF COMPLICATIONS FROM HEALTHCARE-ASSOCIATED INFECTIONS
3. SURGICAL
SITE INFECTION CONTROL MARKET OUTLOOK – BY PROCEDURE
3.1. LAPAROSCOPY
3.2. ORTHOPEDIC
SURGERY
3.3. CARDIOVASCULAR
3.4. OBSTETRICS
AND GYNECOLOGY
3.5. WOUND
CLOSURE
3.6. PLASTIC
& RECONSTRUCTIVE SURGERY
3.7. THORACIC
SURGERY
3.8. MICROVASCULAR
3.9. UROLOGY
3.10. NEUROSURGERY
3.11. OTHER
PROCEDURES
4. SURGICAL
SITE INFECTION CONTROL MARKET OUTLOOK – BY TYPE OF INFECTION
4.1. SUPERFICIAL
INCISIONAL SSI
4.2. DEEP
INCISIONAL SSI
4.3. ORGAN
OR SPACE SSI
5. SURGICAL
SITE INFECTION CONTROL MARKET OUTLOOK – BY INDUSTRY VERTICAL
5.1. HOSPITALS
5.2. AMBULATORY
SURGICAL CENTERS
6. SURGICAL
SITE INFECTION CONTROL MARKET OUTLOOK – BY PRODUCT
6.1. DISINFECTANTS
6.1.1.1. SKIN
DISINFECTANTS
6.1.1.2. HAND DISINFECTANTS
6.2. MANUAL
REPROCESSORS SOLUTION
6.3. SURGICAL
DRAPES
6.4. SURGICAL
GLOVES
6.5. SKIN
PREPARATION SOLUTION
6.6. SURGICAL
IRRIGATION
6.7. SURGICAL
SCRUBS
6.8. HAIR
CLIPPERS
6.9. MEDICAL
NONWOVENS
6.10. OTHER
PRODUCTS
7. SURGICAL
SITE INFECTION CONTROL MARKET - REGIONAL OUTLOOK
7.1. NORTH
AMERICA
7.1.1. MARKET
BY PROCEDURE
7.1.2. MARKET
BY TYPE OF INFECTION
7.1.3. MARKET
BY INDUSTRY VERTICAL
7.1.4. MARKET
BY PRODUCT
7.1.5. COUNTRY
ANALYSIS
7.1.5.1. THE
UNITED STATES
7.1.5.2. CANADA
7.2. EUROPE
7.2.1. MARKET
BY PROCEDURE
7.2.2. MARKET
BY TYPE OF INFECTION
7.2.3. MARKET
BY INDUSTRY VERTICAL
7.2.4. MARKET
BY PRODUCT
7.2.5. COUNTRY
ANALYSIS
7.2.5.1. THE
UNITED KINGDOM
7.2.5.2. GERMANY
7.2.5.3. FRANCE
7.2.5.4. ITALY
7.2.5.5. RUSSIA
7.2.5.6. SPAIN
7.2.5.7. REST
OF EUROPE
7.3. ASIA-PACIFIC
7.3.1. MARKET
BY PROCEDURE
7.3.2. MARKET
BY TYPE OF INFECTION
7.3.3. MARKET
BY INDUSTRY VERTICAL
7.3.4. MARKET
BY PRODUCT
7.3.5. COUNTRY
ANALYSIS
7.3.5.1. CHINA
7.3.5.2. JAPAN
7.3.5.3. INDIA
7.3.5.4. AUSTRALIA
& NEW ZEALAND
7.3.5.5. SOUTH
KOREA
7.3.5.6. ASEAN COUNTRIES
7.3.5.7. REST
OF ASIA-PACIFIC
7.4. LATIN
AMERICA
7.4.1. MARKET
BY PROCEDURE
7.4.2. MARKET
BY TYPE OF INFECTION
7.4.3. MARKET
BY INDUSTRY VERTICAL
7.4.4. MARKET
BY PRODUCT
7.4.5. COUNTRY
ANALYSIS
7.4.5.1. MEXICO
7.4.5.2. BRAZIL
7.4.5.3. REST
OF LATIN AMERICA
7.5. MIDDLE
EAST AND AFRICA
7.5.1. MARKET
BY PROCEDURE
7.5.2. MARKET
BY TYPE OF INFECTION
7.5.3. MARKET
BY INDUSTRY VERTICAL
7.5.4. MARKET
BY PRODUCT
7.5.5. COUNTRY
ANALYSIS
7.5.5.1. ISRAEL
7.5.5.2. SAUDI
ARABIA
7.5.5.3. UNITED
ARAB EMIRATES
7.5.5.4. TURKEY
7.5.5.5. SOUTH
AFRICA
7.5.5.6. REST
OF MIDDLE EAST & AFRICA
8. COMPANY
PROFILES
8.1. SOTERA
HEALTH LLC
8.2. PACON
MANUFACTURING CORPORATION
8.3. STERIS
CORPORATION
8.4. AMERICAN
POLYFILM
8.5. BIOMERIEUX
SA
8.6. STRYKER
CORPORATION
8.7. BELIMED
AG
8.8. GAMA
HEALTHCARE
8.9. BECTON
DICKINSON AND COMPANY (BD)
8.10. 3M
COMPANY
8.11. GETINGE
AB
8.12. JOHNSON
& JOHNSON
8.13. ANSELL
LTD
8.14. KIMBERLY-CLARK
8.15. LAC-MAC
9. RESEARCH
METHODOLOGY & SCOPE
9.1. RESEARCH
SCOPE & DELIVERABLES
9.1.1. OBJECTIVES
OF STUDY
9.1.2. SCOPE
OF STUDY
9.2. SOURCES
OF DATA
9.2.1. PRIMARY
DATA SOURCES
9.2.2. SECONDARY
DATA SOURCES
9.3. RESEARCH
METHODOLOGY
9.3.1. EVALUATION
OF PROPOSED MARKET
9.3.2. IDENTIFICATION
OF DATA SOURCES
9.3.3. ASSESSMENT
OF MARKET DETERMINANTS
9.3.4. DATA
COLLECTION
9.3.5. DATA
VALIDATION & ANALYSIS
TABLE 1 GLOBAL SURGICAL SITE INFECTION CONTROL
MARKET, BY REGION, 2021-2028 (IN $ MILLION)
TABLE 2 VENDOR SCORECARD
TABLE 3 NUMBER OF PERSONS AGED 65 YEARS OR OVER,
BY REGION, 2019 & 2050
TABLE 4 GLOBAL SURGICAL SITE INFECTION CONTROL
MARKET, BY PROCEDURE, 2021-2028 (IN $ MILLION)
TABLE 5 GLOBAL SURGICAL SITE INFECTION CONTROL
MARKET, BY TYPE OF INFECTION, 2021-2028 (IN $ MILLION)
TABLE 6 GLOBAL SURGICAL SITE INFECTION CONTROL
MARKET, BY INDUSTRY VERTICAL, 2021-2028 (IN $ MILLION)
TABLE 7 GLOBAL SURGICAL SITE INFECTION CONTROL
MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)
TABLE 8 GLOBAL DISINFECTANTS MARKET, BY TYPE,
2021-2028 (IN $ MILLION)
TABLE 9 GLOBAL SURGICAL SITE INFECTION CONTROL
MARKET, BY REGION, 2021-2028 (IN $ MILLION)
TABLE 10 NORTH AMERICA SURGICAL SITE INFECTION
CONTROL MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 11 NORTH AMERICA SURGICAL SITE INFECTION
CONTROL MARKET, BY PROCEDURE, 2021-2028 (IN $ MILLION)
TABLE 12 NORTH AMERICA SURGICAL SITE INFECTION
CONTROL MARKET, BY TYPE OF INFECTION, 2021-2028 (IN $ MILLION)
TABLE 13 NORTH AMERICA SURGICAL SITE INFECTION
CONTROL MARKET, BY INDUSTRY VERTICAL, 2021-2028 (IN $ MILLION)
TABLE 14 NORTH AMERICA SURGICAL SITE INFECTION
CONTROL MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)
TABLE 15 EUROPE SURGICAL SITE INFECTION CONTROL
MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 16 EUROPE SURGICAL SITE INFECTION CONTROL
MARKET, BY PROCEDURE, 2021-2028 (IN $ MILLION)
TABLE 17 EUROPE SURGICAL SITE INFECTION CONTROL
MARKET, BY TYPE OF INFECTION, 2021-2028 (IN $ MILLION)
TABLE 18 EUROPE SURGICAL SITE INFECTION CONTROL
MARKET, BY INDUSTRY VERTICAL, 2021-2028 (IN $ MILLION)
TABLE 19 EUROPE SURGICAL SITE INFECTION CONTROL
MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)
TABLE 20 ASIA-PACIFIC SURGICAL SITE INFECTION
CONTROL MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 21 ASIA-PACIFIC SURGICAL SITE INFECTION
CONTROL MARKET, BY PROCEDURE, 2021-2028 (IN $ MILLION)
TABLE 22 ASIA-PACIFIC SURGICAL SITE INFECTION
CONTROL MARKET, BY TYPE OF INFECTION, 2021-2028 (IN $ MILLION)
TABLE 23 ASIA-PACIFIC SURGICAL SITE INFECTION
CONTROL MARKET, BY INDUSTRY VERTICAL, 2021-2028 (IN $ MILLION)
TABLE 24 ASIA-PACIFIC SURGICAL SITE INFECTION
CONTROL MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)
TABLE 25 LATIN AMERICA SURGICAL SITE INFECTION
CONTROL MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 26 LATIN AMERICA SURGICAL SITE INFECTION
CONTROL MARKET, BY PROCEDURE, 2021-2028 (IN $ MILLION)
TABLE 27 LATIN AMERICA SURGICAL SITE INFECTION
CONTROL MARKET, BY TYPE OF INFECTION, 2021-2028 (IN $ MILLION)
TABLE 28 LATIN AMERICA SURGICAL SITE INFECTION
CONTROL MARKET, BY INDUSTRY VERTICAL, 2021-2028 (IN $ MILLION)
TABLE 29 LATIN AMERICA SURGICAL SITE INFECTION
CONTROL MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)
TABLE 30 MIDDLE EAST AND AFRICA SURGICAL SITE
INFECTION CONTROL MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 31 MIDDLE EAST AND AFRICA SURGICAL SITE
INFECTION CONTROL MARKET, BY PROCEDURE, 2021-2028 (IN $ MILLION)
TABLE 32 MIDDLE EAST AND AFRICA SURGICAL SITE
INFECTION CONTROL MARKET, BY TYPE OF INFECTION, 2021-2028 (IN $ MILLION)
TABLE 33 MIDDLE EAST AND AFRICA SURGICAL SITE
INFECTION CONTROL MARKET, BY INDUSTRY VERTICAL, 2021-2028 (IN $ MILLION)
TABLE 34 MIDDLE EAST AND AFRICA SURGICAL SITE
INFECTION CONTROL MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)
FIGURE 1 GLOBAL SURGICAL SITE INFECTION CONTROL
MARKET 2021-2028 (IN $ MILLION)
FIGURE 2 TYPES OF HEALTHCARE-ASSOCIATED INFECTIONS
FIGURE 3 GLOBAL SURGICAL SITE INFECTION CONTROL
MARKET, BY LAPAROSCOPY, 2021-2028 (IN $ MILLION)
FIGURE 4 GLOBAL SURGICAL SITE INFECTION CONTROL
MARKET, BY ORTHOPEDIC SURGERY, 2021-2028 (IN $ MILLION)
FIGURE 5 GLOBAL SURGICAL SITE INFECTION CONTROL
MARKET, BY CARDIOVASCULAR, 2021-2028 (IN $ MILLION)
FIGURE 6 GLOBAL SURGICAL SITE INFECTION CONTROL
MARKET, BY OBSTETRICS AND GYNECOLOGY, 2021-2028 (IN $ MILLION)
FIGURE 7 GLOBAL SURGICAL SITE INFECTION CONTROL
MARKET, BY WOUND CLOSURE, 2021-2028 (IN $ MILLION)
FIGURE 8 GLOBAL SURGICAL SITE INFECTION CONTROL
MARKET, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2021-2028 (IN $ MILLION)
FIGURE 9 GLOBAL SURGICAL SITE INFECTION CONTROL
MARKET, BY THORACIC SURGERY, 2021-2028 (IN $ MILLION)
FIGURE 10 GLOBAL SURGICAL SITE INFECTION CONTROL
MARKET, BY MICROVASCULAR, 2021-2028 (IN $ MILLION)
FIGURE 11 GLOBAL SURGICAL SITE INFECTION CONTROL
MARKET, BY UROLOGY, 2021-2028 (IN $ MILLION)
FIGURE 12 GLOBAL SURGICAL SITE INFECTION CONTROL
MARKET, BY NEUROSURGERY, 2021-2028 (IN $ MILLION)
FIGURE 13 GLOBAL SURGICAL SITE INFECTION CONTROL
MARKET, BY OTHER PROCEDURES, 2021-2028 (IN $ MILLION)
FIGURE 14 GLOBAL SURGICAL SITE INFECTION CONTROL
MARKET, BY SUPERFICIAL INCISIONAL SSI, 2021-2028 (IN $ MILLION)
FIGURE 15 GLOBAL SURGICAL SITE INFECTION CONTROL
MARKET, BY DEEP INCISIONAL SSI, 2021-2028 (IN $ MILLION)
FIGURE 16 GLOBAL SURGICAL SITE INFECTION CONTROL
MARKET, BY ORGAN OR SPACE SSI, 2021-2028 (IN $ MILLION)
FIGURE 17 GLOBAL SURGICAL SITE INFECTION CONTROL
MARKET, BY HOSPITALS, 2021-2028 (IN $ MILLION)
FIGURE 18 GLOBAL SURGICAL SITE INFECTION CONTROL
MARKET, BY AMBULATORY SURGICAL CENTERS, 2021-2028 (IN $ MILLION)
FIGURE 19 GLOBAL SURGICAL SITE INFECTION CONTROL
MARKET, BY DISINFECTANTS, 2021-2028 (IN $ MILLION)
FIGURE 20 GLOBAL DISINFECTANTS MARKET, BY SKIN
DISINFECTANTS, 2021-2028 (IN $ MILLION)
FIGURE 21 GLOBAL DISINFECTANTS MARKET, BY HAND
DISINFECTANTS, 2021-2028 (IN $ MILLION)
FIGURE 22 GLOBAL SURGICAL SITE INFECTION CONTROL
MARKET, BY MANUAL REPROCESSORS SOLUTION, 2021-2028 (IN $ MILLION)
FIGURE 23 GLOBAL SURGICAL SITE INFECTION CONTROL
MARKET, BY SURGICAL DRAPES, 2021-2028 (IN $ MILLION)
FIGURE 24 GLOBAL SURGICAL SITE INFECTION CONTROL
MARKET, BY SURGICAL GLOVES, 2021-2028 (IN $ MILLION)
FIGURE 25 GLOBAL SURGICAL SITE INFECTION CONTROL
MARKET, BY SKIN PREPARATION SOLUTION, 2021-2028 (IN $ MILLION)
FIGURE 26 GLOBAL SURGICAL SITE INFECTION CONTROL
MARKET, BY SURGICAL IRRIGATION, 2021-2028 (IN $ MILLION)
FIGURE 27 GLOBAL SURGICAL SITE INFECTION CONTROL
MARKET, BY SURGICAL SCRUBS, 2021-2028 (IN $ MILLION)
FIGURE 28 GLOBAL SURGICAL SITE INFECTION CONTROL
MARKET, BY HAIR CLIPPERS, 2021-2028 (IN $ MILLION)
FIGURE 29 GLOBAL SURGICAL SITE INFECTION CONTROL
MARKET, BY MEDICAL NONWOVENS, 2021-2028 (IN $ MILLION)
FIGURE 30 GLOBAL SURGICAL SITE INFECTION CONTROL
MARKET, BY OTHER PRODUCTS, 2021-2028 (IN $ MILLION)
FIGURE 31 UNITED STATES SURGICAL SITE INFECTION CONTROL
MARKET 2021-2028 (IN $ MILLION)
FIGURE 32 CANADA SURGICAL SITE INFECTION CONTROL MARKET
2021-2028 (IN $ MILLION)
FIGURE 33 UNITED KINGDOM SURGICAL SITE INFECTION
CONTROL MARKET 2021-2028 (IN $ MILLION)
FIGURE 34 GERMANY SURGICAL SITE INFECTION CONTROL
MARKET 2021-2028 (IN $ MILLION)
FIGURE 35 FRANCE SURGICAL SITE INFECTION CONTROL MARKET
2021-2028 (IN $ MILLION)
FIGURE 36 ITALY SURGICAL SITE INFECTION CONTROL MARKET
2021-2028 (IN $ MILLION)
FIGURE 37 RUSSIA SURGICAL SITE INFECTION CONTROL MARKET
2021-2028 (IN $ MILLION)
FIGURE 38 SPAIN SURGICAL SITE INFECTION CONTROL MARKET
2021-2028 (IN $ MILLION)
FIGURE 39 REST OF EUROPE SURGICAL SITE INFECTION
CONTROL MARKET 2021-2028 (IN $ MILLION)
FIGURE 40 CHINA SURGICAL SITE INFECTION CONTROL MARKET
2021-2028 (IN $ MILLION)
FIGURE 41 JAPAN SURGICAL SITE INFECTION CONTROL MARKET
2021-2028 (IN $ MILLION)
FIGURE 42 INDIA SURGICAL SITE INFECTION CONTROL MARKET
2021-2028 (IN $ MILLION)
FIGURE 43 AUSTRALIA & NEW ZEALAND SURGICAL SITE
INFECTION CONTROL MARKET 2021-2028 (IN $ MILLION)
FIGURE 44 SOUTH KOREA SURGICAL SITE INFECTION CONTROL
MARKET 2021-2028 (IN $ MILLION)
FIGURE 45 ASEAN COUNTRIES SURGICAL SITE INFECTION
CONTROL MARKET 2021-2028 (IN $ MILLION)
FIGURE 46 REST OF ASIA-PACIFIC SURGICAL SITE INFECTION
CONTROL MARKET 2021-2028 (IN $ MILLION)
FIGURE 47 LATIN AMERICA SURGICAL SITE INFECTION CONTROL
MARKET 2021-2028 (IN $ MILLION)
FIGURE 48 MEXICO SURGICAL SITE INFECTION CONTROL MARKET
2021-2028 (IN $ MILLION)
FIGURE 49 BRAZIL SURGICAL SITE INFECTION CONTROL MARKET
2021-2028 (IN $ MILLION)
FIGURE 50 REST OF LATIN AMERICA SURGICAL SITE INFECTION
CONTROL MARKET 2021-2028 (IN $ MILLION)
FIGURE 51 MIDDLE EAST AND AFRICA SURGICAL SITE
INFECTION CONTROL MARKET 2021-2028 (IN $ MILLION)
FIGURE 52 ISRAEL SURGICAL SITE INFECTION CONTROL MARKET
2021-2028 (IN $ MILLION)
FIGURE 53 SAUDI ARABIA SURGICAL SITE INFECTION CONTROL
MARKET 2021-2028 (IN $ MILLION)
FIGURE 54 UNITED ARAB EMIRATES SURGICAL SITE INFECTION
CONTROL MARKET 2021-2028 (IN $ MILLION)
FIGURE 55 TURKEY SURGICAL SITE INFECTION CONTROL MARKET
2021-2028 (IN $ MILLION)
FIGURE 56 SOUTH AFRICA SURGICAL SITE INFECTION CONTROL
MARKET 2021-2028 (IN $ MILLION)
FIGURE 57 REST OF MIDDLE EAST & AFRICA SURGICAL
SITE INFECTION CONTROL MARKET 2021-2028 (IN $ MILLION)